GB1058340A - Transmissible gastroenteritis vaccines and method of producing the same - Google Patents

Transmissible gastroenteritis vaccines and method of producing the same

Info

Publication number
GB1058340A
GB1058340A GB40379/65A GB4037965A GB1058340A GB 1058340 A GB1058340 A GB 1058340A GB 40379/65 A GB40379/65 A GB 40379/65A GB 4037965 A GB4037965 A GB 4037965A GB 1058340 A GB1058340 A GB 1058340A
Authority
GB
United Kingdom
Prior art keywords
virus
vaccine
sow
pigs
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB40379/65A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIAMOND LAB Inc
Original Assignee
DIAMOND LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIAMOND LAB Inc filed Critical DIAMOND LAB Inc
Publication of GB1058340A publication Critical patent/GB1058340A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225Porcine transmissible gastroenteritis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20061Methods of inactivation or attenuation
    • C12N2770/20064Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB40379/65A 1964-09-22 1965-09-22 Transmissible gastroenteritis vaccines and method of producing the same Expired GB1058340A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39839864A 1964-09-22 1964-09-22

Publications (1)

Publication Number Publication Date
GB1058340A true GB1058340A (en) 1967-02-08

Family

ID=23575249

Family Applications (1)

Application Number Title Priority Date Filing Date
GB40379/65A Expired GB1058340A (en) 1964-09-22 1965-09-22 Transmissible gastroenteritis vaccines and method of producing the same

Country Status (10)

Country Link
BE (1) BE669881A (enrdf_load_stackoverflow)
CH (1) CH466894A (enrdf_load_stackoverflow)
DE (1) DE1253412B (enrdf_load_stackoverflow)
DK (1) DK109407C (enrdf_load_stackoverflow)
FR (1) FR1563628A (enrdf_load_stackoverflow)
GB (1) GB1058340A (enrdf_load_stackoverflow)
LU (1) LU49501A1 (enrdf_load_stackoverflow)
NL (1) NL6512094A (enrdf_load_stackoverflow)
NO (1) NO119491B (enrdf_load_stackoverflow)
SE (1) SE358657B (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
EP0310316A3 (en) * 1987-09-28 1990-02-14 Beecham Inc. Novel vaccine
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US6074651A (en) * 1988-09-14 2000-06-13 Pfizer, Inc. Vaccine based on TGEV for protection of canines against canine coronavirus

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
EP0310316A3 (en) * 1987-09-28 1990-02-14 Beecham Inc. Novel vaccine
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US6074651A (en) * 1988-09-14 2000-06-13 Pfizer, Inc. Vaccine based on TGEV for protection of canines against canine coronavirus

Also Published As

Publication number Publication date
NL6512094A (enrdf_load_stackoverflow) 1966-03-23
BE669881A (enrdf_load_stackoverflow) 1966-03-21
NO119491B (enrdf_load_stackoverflow) 1970-05-25
DE1253412B (de) 1967-11-02
CH466894A (de) 1968-12-31
LU49501A1 (enrdf_load_stackoverflow) 1966-03-21
FR1563628A (enrdf_load_stackoverflow) 1969-04-18
SE358657B (enrdf_load_stackoverflow) 1973-08-06
DK109407C (da) 1968-04-22

Similar Documents

Publication Publication Date Title
Pye Vaccination of sheep with cell culture grown orf virus
de Baugés et al. Effect of antibiotic therapy and strain-19 vaccination on the spread of Brucella melitensis within an infected dairy herd
US3155589A (en) Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
NO159782B (no) Anordning ved fjaersystem, foerst og fremst paa kjoeretoeyer.
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
US4320115A (en) Rabies virus vaccine
US3479430A (en) Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same
Schipper et al. Evaluation of inactivated infectious bovine rhinotracheitis vaccines
GB1071922A (en) Improvements in or relating to vaccines
Owen et al. Bluetongue in cattle: typing of viruses isolated from cattle exposed to natural infections
US3562387A (en) Mink virus enteritis vaccine and method for the production thereof
US3585108A (en) Transmissible gastroenteritis vaccines and methods of producing the same
US3000788A (en) Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
US3704203A (en) Transmissible gastroenteritis vaccines and methods of producing the same
JP3043353B2 (ja) ワクチン
US3725542A (en) Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it
RU2194530C1 (ru) Ассоциированная вакцина для профилактики заболеваний пушных зверей
US3122477A (en) Hog cholera vaccine and method of making the same
Pipana Virulence and immunogenicity of cultured Theileria annulata schizonts
Dalsgaard et al. Saponin adjuvants. VI. The adjuvant activity of quil A in trivalent vaccination of cattle and guinea pigs against foot-and-mouth disease
UA117089U (uk) Вакцина "ссіт" інактивована для специфічної профілактики захворювань стрептококової, ентерококової та стафілококової етіології
RU1459002C (ru) Вакцина против инфекционного гепатита плотоядных и способ профилактики инфекционного гепатита плотоядных
RU2035190C1 (ru) Способ предотвращения вирусных заболеваний сельскохозяйственных животных
DALLING The control of diseases of livestock